ArticleJournal of hepatocellular carcinoma2025
MRI-Based Deep Learning and Radiomics Nomogram for Predicting Hepatocellular Carcinoma Recurrence Within Six Months After Thermal Ablation.
Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A bibliometric analysis of research trends and hotspots on recurrence after thermal ablation for hepatocellular carcinoma 2005-2025.Discover oncology · 2026Article
- Development and Validation of a Clinical Radiomics Nomogram for Predicting Early Recurrence After Microwave Ablation in Hepatocellular Carcinoma Patients With Type 2 Diabetes.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Develop a magnetic resonance imaging (MRI)-based deep learning (DL)-radiomics (Rad)-clinical nomogram for predicting early recurrence of hepatocellular carcinoma (HCC) within six months after thermal ablation. Materials and Methods: Barcelona Clinic Liver Cancer (BCLC) stage 0-A HCC patients who underwent dynamic contrast-enhanced MRI before ablation were retrospectively included. Patients were categorized into non early recurrence and early recurrence groups. A clinical model was constructed through logistic regression analysis of clinical information and radiological features. DL score model and Rad score model were developed using DL features and manual features extracted from dynamic contrast-enhanced MRI, with principal component analysis and least absolute shrinkage and selection operator regression methods. The DL-Rad-Clinical nomogram was constructed through logistic regression analysis. The model performance was primarily evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 224 patients were included in this study (training set: n = 156; test set: n = 68). The DL-Rad-Clinical nomogram was constructed, including Rad score, DL score, natural logarithm alpha-fetoprotein (LnAFP), and multiple low signal lesions as predictive factors. In the training set, the DL-Rad-Clinical nomogram demonstrated better predictive performance (AUC = 0.896, P < 0.05). In the test set, the DL-Rad-Clinical nomogram had a higher AUC value compared to other models, although the difference was not statistically significant (AUC = 0.774, P > 0.05). Conclusion: The DL-Rad-Clinical nomogram helped in identifying HCC patients with early recurrence within six months following thermal ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.